APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 249 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,178,600 | -52.7% | 215,000 | +13.2% | 0.88% | -51.7% |
| Q2 2023 | $17,309,000 | +41.7% | 190,000 | +2.7% | 1.82% | +36.1% |
| Q1 2023 | $12,213,700 | +18.1% | 185,000 | -7.5% | 1.34% | +24.3% |
| Q4 2022 | $10,342,000 | -22.3% | 200,000 | -9.1% | 1.08% | -22.5% |
| Q3 2022 | $13,308,000 | +40.1% | 220,000 | +4.8% | 1.39% | +29.1% |
| Q2 2022 | $9,496,000 | -50.4% | 210,000 | -44.3% | 1.08% | -42.9% |
| Q1 2022 | $19,155,000 | -7.1% | 377,000 | -12.3% | 1.89% | +37.9% |
| Q4 2021 | $20,619,000 | +11.5% | 430,000 | -23.4% | 1.37% | +5.6% |
| Q3 2021 | $18,499,000 | -4.0% | 561,269 | +84.0% | 1.30% | -0.8% |
| Q2 2021 | $19,276,000 | +66.4% | 305,000 | +13.0% | 1.31% | +61.9% |
| Q1 2021 | $11,586,000 | -25.0% | 270,000 | 0.0% | 0.81% | -35.9% |
| Q4 2020 | $15,444,000 | +127.5% | 270,000 | +20.0% | 1.26% | +108.6% |
| Q3 2020 | $6,788,000 | +26.0% | 225,000 | +36.4% | 0.60% | +3.8% |
| Q2 2020 | $5,389,000 | +101.2% | 165,000 | +65.0% | 0.58% | +55.2% |
| Q1 2020 | $2,679,000 | +9.3% | 100,000 | +25.0% | 0.38% | +39.9% |
| Q4 2019 | $2,450,000 | – | 80,000 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |